Clinical trial
To Investigate the Expression of Target in Endometriotic Lesions
NCT07693283 is registered in ClinicalTrials.gov with Beijing Tsinghua Chang Gung Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Investigate the Expression of Target in Endometriotic Lesions
- Lead sponsor
- Beijing Tsinghua Chang Gung Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 13, 2026
- Completion date
- February 12, 2027
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.